Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-14-000348
Filing Date
2014-03-28
Accepted
2014-03-28 18:20:09
Documents
1
Period of Report
2014-03-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3943
  Complete submission text file 0000904454-14-000348.txt   5526
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O A.P. PHARMA, INC. 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address
Gelder Mark S. MD (Reporting) CIK: 0001564390 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33221 | Film No.: 14727203